Literature DB >> 20110655

Nomenclature evolution: Changes in the ISCN from the 2005 to the 2009 edition.

A R Brothman1, D L Persons, L G Shaffer.   

Abstract

The Committee for the International System for Human Cytogenetic Nomenclature (ISCN) has recently met and published a revised version, ISCN 2009. Multiple changes in nomenclature guidelines are presented in that updated version. This review will highlight changes to the idiograms and specific changes in respective chapters of the 2009 version compared with the previous version of the ISCN published in 2005. These highlights are meant as a guide for the cytogeneticist to assist in the transition in the use of this updated nomenclature for describing cytogenetic and molecular cytogenetic findings in both clinical and research reports. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20110655     DOI: 10.1159/000279442

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  50 in total

1.  Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.

Authors:  Annemarie Koch; Jiri Hatina; Harald Rieder; Hans-Helge Seifert; Wolfgang Huckenbeck; Frank Jankowiak; Andrea R Florl; Robert Stoehr; Wolfgang A Schulz
Journal:  Cell Oncol (Dordr)       Date:  2012-06-06       Impact factor: 6.730

2.  Advanced comparative cytogenetic analysis of X chromosomes in river buffalo, cattle, sheep, and human.

Authors:  A Perucatti; V Genualdo; A Iannuzzi; A Rebl; D Di Berardino; T Goldammer; Leopoldo Iannuzzi
Journal:  Chromosome Res       Date:  2012-06-06       Impact factor: 5.239

3.  Response to imatinib mesylate in patients with hypereosinophilic syndrome.

Authors:  Maryam Arefi; Juan L García; M Montserrat Briz; Felipe de Arriba; Juan N Rodríguez; Guillermo Martín-Núñez; Joaquín Martínez; Javier López; Julio G Suárez; M José Moreno; M Angeles Merino; Norma C Gutiérrez; Jesús Marίa Hernández-Rivas
Journal:  Int J Hematol       Date:  2012-07-18       Impact factor: 2.490

4.  A balanced translocation truncates Neurotrimin in a family with intracranial and thoracic aortic aneurysm.

Authors:  Tiia M Luukkonen; Minna Pöyhönen; Aarno Palotie; Pekka Ellonen; Sonja Lagström; Joseph H Lee; Joseph D Terwilliger; Riitta Salonen; Teppo Varilo
Journal:  J Med Genet       Date:  2012-10       Impact factor: 6.318

5.  Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry.

Authors:  T Bernal; P Martínez-Camblor; J Sánchez-García; R de Paz; E Luño; B Nomdedeu; M T Ardanaz; C Pedro; M L Amigo; B Xicoy; C del Cañizo; M Tormo; J Bargay; D Valcárcel; S Brunet; L Benlloch; G Sanz
Journal:  Leukemia       Date:  2015-05-06       Impact factor: 11.528

6.  Three-way complex variant translocation involving short arm chromosome (1;9;22)(p36;q34;q11) in a chronic myeloid leukemia patient.

Authors:  Muhammad Asif; Abrar Hussain; Arif Malik; Mahmood Rasool
Journal:  Oncol Lett       Date:  2015-07-15       Impact factor: 2.967

7.  Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment.

Authors:  Maximilian Fleischmann; Ulf Schnetzke; Karin G Schrenk; Volker Schmidt; Herbert G Sayer; Inken Hilgendorf; Andreas Hochhaus; Sebastian Scholl
Journal:  J Cancer Res Clin Oncol       Date:  2016-10-24       Impact factor: 4.553

8.  Co-existence of isodicentric Ph chromosomes and the three-way Ph chromosome variant t(3;9;22)(p21;q34;q11) in a rare case of chronic myeloid leukemia.

Authors:  Qian Li; Xiao-Ji Lin; Hui Chen; Jian Gong; Zhen Li; Xiang-Nan Chen
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

9.  Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML.

Authors:  Harald Herrmann; Irina Sadovnik; Gregor Eisenwort; Thomas Rülicke; Katharina Blatt; Susanne Herndlhofer; Michael Willmann; Gabriele Stefanzl; Sigrid Baumgartner; Georg Greiner; Axel Schulenburg; Niklas Mueller; Werner Rabitsch; Martin Bilban; Gregor Hoermann; Berthold Streubel; Daniel A Vallera; Wolfgang R Sperr; Peter Valent
Journal:  Blood Adv       Date:  2020-10-27

10.  Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study.

Authors:  Roberto Latagliata; Dario Ferrero; Alessandra Iurlo; Francesco Cavazzini; Fausto Castagnetti; Elisabetta Abruzzese; Carmen Fava; Massimo Breccia; Mario Annunziata; Fabio Stagno; Mario Tiribelli; Gianni Binotto; Giovanna Mansueto; Antonella Gozzini; Sabina Russo; Laura Cavalli; Enrico Montefusco; Gabriele Gugliotta; Michele Cedrone; Antonella Russo Rossi; Paolo Avanzini; Patrizia Pregno; Endri Mauro; Antonio Spadea; Francesca Celesti; Gianfranco Giglio; Alessandro Isidori; Monica Crugnola; Elisabetta Calistri; Federica Sorà; Stefano Storti; Ada D'Addosio; Giovanna Rege-Cambrin; Luigiana Luciano; Giuliana Alimena
Journal:  Drugs Aging       Date:  2013-08       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.